Chemicals

(2R)-2-acetamido-4-methylpentanoic acid

We are (2R)-2-acetamido-4-methylpentanoic acid CAS:19764-30-8 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

Chemical Name: (2R)-2-acetamido-4-methylpentanoic acid

CAS.NO: 19764-30-8

Molecular Formula:C8H15NO3

Molecular Weight:173.21000

Synonyms:

Ac-D-Leu-OH

D-leucine,N-acetyl

D-Leucine, N-acetyl-

N-Ac-D-leucine

2,N-Acetyl-D-leucine

N-Acetyl-D-leucine

(R)-N-acetyl-leucine

(R)-2-Acetamido-4-methylpentanoic acid

N-acetylleucin

N-Acetyl-D-leucin

(2R)-2-acetamido-4-methylpentanoic acid

N-Acethy-D-leucine

Physical and Chemical Properties:

Density: 1.069 g / cm3

Boiling point: 369.7ºC at 760 mmHg

Melting point: 176-177ºC

Flash point: 177.4ºC

Refractive index: 1.458

Specification:

Appearance: White to off-white powder

Purity:≥99%

Residue on ignition:≤0.3%

Loss on drying:≤0.5%

Packing:25 kg/drum, can also be packaged according to customer requirements

Storage:Store at -20ºC.Keep the container tightly closed, put it in a tight dispenser, and store in a cool, dry place.

Application:Acetylleucine is a drug used in the treatment of vertigo.

(2R)-2-acetamido-4-methylpentanoic acid

Related News: The workers are demanding that Hong Kong close all border checkpoints to visitors from mainland China, saying they represent a threat to health care workers in the city.(2,5-dioxopyrrolidin-1-yl) 2-(9H-fluoren-9-ylmethoxycarbonylamino)-3-methylbutanoate In 2016, the export volume of China’s specialty drug substances reached US $ 3.53 billion, accounting for 13.8% of the total drug substances.116-11-0 In 2016, the export volume of China’s specialty drug substances reached US $ 3.53 billion, accounting for 13.8% of the total drug substances.280773-16-2 In 2016, the export volume of China’s specialty drug substances reached US $ 3.53 billion, accounting for 13.8% of the total drug substances.Different cell types can be affected, although the most common finding in MDS is a shortage of red blood cells (anaemia). Patients with higher-risk MDS may progress to the development of acute leukaemia.

Product Name
DIBENZO-18-CROWN-6 Cas:14187-32-7	View Details
1-Methyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole Cas:761446-44-0	View Details
Estriol Cas:50-27-1	View Details